Back to search

A1 Pharmaceuticals Holdings Limited

08511438

active
Private Limited Company
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

UNIT 20 & 21 EASTER INDUSTRIAL PARK, RAINHAM, RM13 9BP
Incorporated 30/04/2013

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

21100
Manufacture of basic pharmaceutical products
46460
Wholesale of pharmaceutical goods

Officers

Mrs Carmen Lewis

director · Since 30/04/2013

SECRETARY ADMINISTRATOR

BRITISH · ENGLAND · Age 61

Also on 9 other boards

Mr Gary Stephen Lewis Bsc(Hons) Mr(Pharms)

director · Since 30/04/2013

PHARMACIST

BRITISH · UNITED KINGDOM · Age 66

Also on 9 other boards

Henry Thomas John Lewis

director · Since 01/08/2019

DIRECTOR

BRITISH · UNITED KINGDOM · Age 38

Also on 3 other boards

Mr Thomas William Lewis

director · Since 01/08/2019

DIRECTOR

BRITISH · ENGLAND · Age 36

Persons with Significant Control

Mr Gary Stephen Lewis

25–50% shares
25–50% votes
Appoint directors
significant-influence-or-control-as-firm

British · United Kingdom · Age 66

Unit 20, & 21 Easter Industrial Park, Rainham, RM13 9BP

Notified 01/05/2016

Mrs Carmen Lewis

25–50% shares
25–50% votes
Appoint directors
significant-influence-or-control-as-firm

British · England · Age 61

Unit 20, & 21 Easter Industrial Park, Rainham, RM13 9BP

Notified 21/11/2025

CompanyRankvs 137+ SIC 21100 peers
64

Financial strength55th percentile among SIC peers · 14/25
Employees81th percentile among SIC peers · 12/15
LiquidityCurrent ratio 9.64× · 20/20
Longevity13 years trading (max 15) · 13/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Lofthouse Of Fleetwood Limited
90
2West Pharmaceutical Services Cornwall Limited
90
3Dr. Reddy'S Laboratories (Eu) Limited
90
4Mw Encap Limited
90
5Rsr Limited
90
6Aura-Soma Products Limited
89
7Tcs Biosciences Limited
89
8Pharmapac (U.K.) Limited
89
9Onyx Scientific Limited
89
10International Scientific Supplies Limited
89
137A1 Pharmaceuticals Holdings Limited
74
How is this score calculated?
Financial strength14/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity13/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's or the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going c

Key FinancialsYear ending 30/04/2025

Net Worth

£1k

Balance sheet strength

Cash

—

Cash in the bank

Net Current Assets

£15.1M

Working capital

Current Assets

£15.1M

Current Liabilities

£1.6M

Fixed Assets

£49k

Debtors

£15.1M

Profit After Tax

£2.7M

4avg. employees

Tax at Year End

Dividends paid£162k

Balance Sheet

Assets less current liabilities£15.1M
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20259.64—
20249.04+£1.5M
202323.71—
20229.52—
20217.69—
20204.60—

Derived from filed accounts. Not audited figures.